A vaginal yeast infection is a fungal infection that causes irritation, discharge, and intense itchiness of the vagina and the vulva — the tissues at the vaginal opening. Vaginal fungi infection is also known as vaginal yeast infection, vulvovaginal candidiasis, candidal vaginitis or vaginal candidiasis, and it the second most common type of vaginal infection in the U.S., according the Centers for Disease Control and Prevention.
Market Dynamics
Rising incidence of vaginal fungi infections are driving vaginal fungi infections treatment market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), 2018, around 1.4 million outpatient visits occur for vaginal candidiasis every year in the U.S. Moreover, according to an article published in Multidisciplinary Digital Publishing Institute (MDPI) in February 2020, Vulvovaginal candidiasis (VVC) is the most prevalent human candidal infection and nearly 75% women across the globe are affected by it least once in their lifetime. Furthermore, according to the same source, around 8% women across the globe suffer from Recurrent Vulvovaginal Candidiasis (RVVC).
However, alternative therapies for vaginal fungi infections treatment can hinder the market growth. For instance, Nutrablast, a dedicated company in the dietary supplement and personal care offers Tea Tree Suppositories for vaginal fungi infections treatment. The product is natural tea tree oil to provide a balanced vaginal environment.
Key features of the study
• This report provides in-depth analysis of the global vaginal fungi infections treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Vaginal Fungi Infections Treatment Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, and SCYNEXIS, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
• The global Vaginal Fungi Infections Treatment Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaginal fungi infections treatment market.
Market Segmentation
• By Drug Type (Revenue, USD Mn, 2021-2033)
o Fluconazole
o Nystatin
o Flucytosine
o Others
• By Route of Administration (Revenue, USD Mn, 2021-2033)
o Oral
o Topical
• By Distribution Channel (Revenue, USD Mn, 2021-2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies.
• By Region (Revenue, USD Mn, 2021-2033)
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 Germany
 U.K.
 France
 Italy
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 GCC
 Israel
 Rest of Middle East
o Africa
 South Africa
 Central Africa
 North Africa
• Competitive Landscape
o Pfizer Inc.
o Bausch Health Companies Inc
o ANI Pharmaceuticals, Inc.
o Hikma Pharmaceuticals Plc
o Lupin Limited, Mycovia Pharmaceuticals, Inc.
o Glenmark Pharmaceuticals Limited
o Unique Pharmaceuticals
o PEPTONIC medical AB
o Aurobindo Pharma Limited
o Reddy's Laboratories
o SCYNEXIS, Inc.

Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Drug Type
 Market Snippet, By Route of Administration
 Market Snippet, By Distribution Channel
 Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Pipeline Analysis
o Reimbursement Scenario
o Epidemiology
o Pest Analysis
o Regulatory Scenario
o New Product Launches
o Collaborations and Agreements
o Market Trends
4. Global Vaginal Fungi Infections Treatment Market, By Drug Type, 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 – 2033
 Segment Trends
o Fluconazole
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Nystatin
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Flucytosine
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
5. Global Vaginal Fungi Infections Treatment Market, By Route of Administration, 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 – 2033
 Segment Trends
o Oral
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Topical
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
6. Global Vaginal Fungi Infections Treatment Market, By Distribution Channel, 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 – 2033
 Segment Trends
o Hospital Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Retail Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
o Online Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021– 2033, (US$ Mn)
7. Global Vaginal Fungi Infections Treatment Market, By Region, 2021– 2033, (US$ Mn)
o Introduction
 Market Share Analysis, By Region, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
 Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o U.S.
o Canada
o Latin America
 Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
 Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
 Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
 Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Country, 2021– 2033, (US$ Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
 Market Size and Forecast, By Drug Type, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Route of Administration, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Distribution Channel, 2021– 2033, (US$ Mn)
 Market Size and Forecast, By Country/Region, 2021– 2033, (US$ Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
 Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Bausch Health Companies Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 ANI Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Hikma Pharmaceuticals Plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Lupin Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Mycovia Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Glenmark Pharmaceuticals Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Unique Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 PEPTONIC medical AB
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Aurobindo Pharma Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Reddy's Laboratories
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 SCYNEXIS, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
Browse 37 market data tables and 25 figures on Vaginal Fungi Infections Treatment Market” - Global forecast to 2033